InvestSMART

Bionomics Limited (ASX: BNO) - Announcements

DELISTED - Current share price for BNO : $0.010

ASX company news and announcements for Bionomics Limited (BNO) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bionomics Limited (BNO) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bionomics Limited (BNO), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bionomics Limited (BNO)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 4C - quarterly 31 Jan 2014 9:57AM $0.720 $0.010 fallen by 98.61%
- Bionomics Receives $7.04M 2013 R&D Tax Incentive 18 Dec 2013 9:44AM $0.700 $0.010 fallen by 98.57%
- Appendix 4C - quarterly 31 Oct 2013 3:55PM $0.700 $0.010 fallen by 98.57%
- Bionomics R&D Tax Incentive For FY2013 8 Oct 2013 10:02AM $0.760 $0.010 fallen by 98.68%
- Bionomics 2012/2013 Preliminary Final Results 15 Aug 2013 3:59PM $0.640 $0.010 fallen by 98.44%
- Bionomics Signs Option and License Agreement with Merck 31 Jul 2013 9:34AM $0.550 $0.010 fallen by 98.18%
- Appendix 4C - quarterly 30 Jul 2013 3:38PM $0.455 $0.010 fallen by 97.80%
- Bionomics initiates IND-enabling studies with BNC101 29 Jul 2013 9:47AM $0.405 $0.010 fallen by 97.53%
- BNO completes enrolment in Phase II renal cancer trial 11 Jun 2013 9:50AM $0.370 $0.010 fallen by 97.30%
- BNC105 Trials Presented at ASCO 3 Jun 2013 9:22AM $0.390 $0.010 fallen by 97.44%
- CTX AND BIONOMICS' PROGRAM REACHES KEY MILESTONE 16 May 2013 10:08AM $0.405 $0.010 fallen by 97.53%
- Appendix 4C - quarterly 30 Apr 2013 3:35PM $0.380 $0.010 fallen by 97.37%
- Manufacture of BNC101 commences at Lonza 23 Apr 2013 10:08AM $0.375 $0.010 fallen by 97.33%
- Underwritten Rights Issue Offer Booklet 4 Mar 2013 9:59AM $0.390 $0.010 fallen by 97.44%
- Underwritten Rights Issue to Raise $16.4 Million 4 Mar 2013 9:25AM $0.390 $0.010 fallen by 97.44%
- Trading Halt 28 Feb 2013 9:25AM $0.410 $0.010 fallen by 97.56%
- Half Yearly Report and Accounts 14 Feb 2013 3:53PM $0.430 $0.010 fallen by 97.67%
- BNO Provides BNC101 Update at US Cancer Stem Cell Conference 11 Feb 2013 10:17AM $0.435 $0.010 fallen by 97.70%
- BNC375 Alzheimer's Disease Data Presented at Conference 4 Feb 2013 10:00AM $0.405 $0.010 fallen by 97.53%
- Appendix 4C - quarterly 31 Jan 2013 2:57PM $0.400 $0.010 fallen by 97.50%
- Bionomics R&D Tax Incentive for FY2012 15 Jan 2013 10:07AM $0.400 $0.010 fallen by 97.50%
- CEO Update and US Investor Presentation 9 Jan 2013 10:35AM $0.365 $0.010 fallen by 97.26%
- BNC210 US TRIAL 21 Dec 2012 10:09AM $0.350 $0.010 fallen by 97.14%
- Bionomics New Alzheimer's Drug Candidate 14 Dec 2012 10:26AM $0.350 $0.010 fallen by 97.14%
- CEO & Managing Director AGM Presentation 2012 14 Nov 2012 11:15AM $0.320 $0.010 fallen by 96.88%

576 - 600 of 801 results

Page 24 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.